Viking Therapeutics, Inc.
VKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001607678
In the last 90 days, Viking Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 437 institutions reported holding it in 13F filings for Q2 2026, worth $2.96B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Viking Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 129 | 1 | 185 | +57 |
| Shares | 34.1M | 14.0K | 66.5M | +32.4M (+94.8%) |
| Value | $319.7M | $131.6K | $1.11B | +$787.4M (+246.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (75)
Institutions that held Viking Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (18)
Institutions that held Viking Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Deep Track Capital, LP | 610,083 | $5.73M |
| Invesco Ltd. | 258,322 | $2.43M |
| EAM Global Investors LLC | 211,228 | $1.99M |
| Moore Capital Management, LP | 100,000 | $940.0K |
| Cheyne Capital Management (UK) LLP | 64,753 | $608.7K |
| Jump Financial, LLC | 56,800 | $533.9K |
| Caxton Associates LP | 41,622 | $391.2K |
| Lighthouse Investment Partners, LLC | 30,578 | $287.4K |
| Amussen Hunsaker Associates LLC | 21,980 | $206.6K |
| Mirabella Financial Services LLP | 20,178 | $189.7K |
| Tectonic Advisors LLC | 20,000 | $188.0K |
| SG Americas Securities, LLC | 10,684 | $100.0K |
| Cambridge Investment Research Advisors, Inc. | 10,113 | $95.0K |
| Herr Investment Group LLC | 10,100 | $94.9K |
| Brinker Capital Investments, LLC | 10,055 | $94.5K |
| Rockefeller Capital Management L.P. | 1,461 | $13.0K |
| SOA Wealth Advisors, LLC. | 1,230 | $11.6K |
| FNY Investment Advisers, LLC | 40 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Viking Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Titleist Asset Management, Ltd. | 14,000 | $131.6K |